---
schema_version: "secwatch.filing_event.v1"
accession: "0001944048-24-000007"
form_type: "8-K"
ticker: "KVUE"
cik: "0001944048"
company_name: "Kenvue Inc."
filed_at: "2024-02-08T23:59:59+00:00"
generated_at: "2026-06-06T05:57:19.418664+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Kenvue reports FY23 revenue $15.4B (+3.3%); Q4 revenue down 2.7%; guides FY24 adjusted EPS $1.10-1.20

## Summary
- FY23 net sales $15.4B, +3.3%; organic growth 5.0%; adjusted diluted EPS $1.29.
- Q4 net sales $3.7B, -2.7%; organic decline 2.4%; adjusted EPS $0.31.
- FY23 diluted EPS $0.90 (GAAP); adjusted $1.29.
- FY24 outlook: net sales growth 1-3%, organic 2-4%; adjusted EPS $1.10-$1.20, below FY23.
- CEO cites U.S. Skin Health/Beauty weakness; expects sequential improvement in 2024.

## SEC filing metadata
- accession: 0001944048-24-000007
- form_type: 8-K
- ticker: KVUE
- cik: 0001944048
- company_name: Kenvue Inc.
- filed_at: 2024-02-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/0001944048-24-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/kvue-20240208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001944048-24-000007
- JSON: https://secwatch.observer/filing/0001944048-24-000007.json
- Plain text: https://secwatch.observer/filing/0001944048-24-000007.txt

## Key facts
- Earnings Releases
  Kenvue Inc. reported the fiscal full year and fourth quarter ended December 31, 2023 results: revenue $15.4 billion, EPS $0.90. Guidance initiated.
  - Period: the fiscal full year and fourth quarter ended December 31, 2023
  - Revenue: $15.4 billion
  - EPS: $0.90
  - Guidance: initiated
  - Result: reported results
  source text: Kenvue Reports Full Year and Fourth Quarter 2023 Results FY'23: Net Sales Increased 3.3% to $15.4 billion with Organic Growth 1 of 5.0% FY'23: Diluted Earnings per Share of $0.90; Adjusted Diluted Earnings per Share 1 of $1.29 Q4'23: Net Sales Decreased (2.7)% to $3.7 billion with Organic Growth 1 of (2.4)% Q4'23: Diluted Earnings per Share of $0.17; Adjusted Diluted Earnings per Share 1 of $0.31
  evidence_url: https://www.sec.gov/Archives/edgar/data/1944048/000194404824000007/0001944048-24-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.